Claudio Albrecht

Romania still core of cancer drug business for Actavis

Claudio Albrecht, CEO of Actavis drug maker, with 1.7bn-euro turnover in 2010, which owns Sindan plant in Romania, says a Swiss or an Austrian would not have the same results as the Romanian team, with Romanians having capacity for improvisation, being intelli...